It's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.

from MarketWatch.com - Top Stories https://ift.tt/3AxHYve
via IFTTT
from MarketWatch.com - Top Stories https://ift.tt/3AxHYve
via IFTTT
Kommentare
Kommentar veröffentlichen